Further studies are needed to determine how HtrA1-mediated proteolysis of DKK3, RBP3, and CLU may relate to genetic variation in the HtrA1/ARMS2 region and the risk for AMD and the progression of established AMD. The gene discussed is DKK3; the disease is age-related macular degeneration.